Subscribe to our news feed
A question?
3/15/2024
NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)
The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Monday, April 22, 2024 at 3.00 p.m. CEST, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. Entrance registration starts at 2.00 p.m. CEST. A lighter snack will be served after the AGM.
The Board of Directors of Getinge has decided to allow the shareholders to also attend the AGM by postal voting in accordance with the regulations in Getinge’s Articles of Association as further described below.
Further information regarding postal voting is also available on the company’s website, https://www.getinge.com/int/company/corporate-governance/general-meetings/annual-general-meeting-2024/.
3/13/2024
Sanquin's role in advancing blood supply and medical research
Sanquin, a cornerstone of the Dutch healthcare system, is not just a blood supply organization; it is a hub of innovation and research, dedicated to advancing the field of transfusion medicine and cell therapy. Established in 1998, Sanquin has been fundamental in ensuring a safe and efficient blood supply in the Netherlands, employing around 2,000 workers across the nation.
3/8/2024
Getinge takes a leap forward in cardiovascular surgery with the 510(k) clearance for Vasoview Hemopro 3
Today, Getinge announces the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview Hemopro 3, the latest addition to the medtech company’s endoscopic vessel harvesting (EVH) solutions. Designed with customer centricity top of mind, the newcomer is expected to offer enhanced procedural efficiency in healthcare from the upcoming launch.
3/7/2024
Getinge launches intuitive and high-performance multi-chamber washer-disinfector
Getinge’s new multi-chamber washer-disinfector, Aquadis Index combines high capacity with low utility consumption, to help Central Sterile Supply Department (CSSD) staff around the world meet both productivity and sustainability goals.
3/1/2024
TÜV SÜD is temporarily suspending Getinge’s CE certificate for Cardiosave
The notified body, TÜV SÜD, is temporarily suspending the CE certificate for Getinge’s Cardiosave Intra-Aortic Balloon Pump with immediate effect. Getinge is given six months to adhere to the required corrective actions. The financial impact is not expected to be material for Getinge.
2/27/2024
A runner with passion for helping vaccines get to the finishing line
No matter if she is assisting researchers in the development of life-saving vaccines, or helping young, talented Swedish athletes realize their championship dreams, Charlotte Schönbeck is powered by the belief that science is the key to the future – and she is in it for the long run.
Press Contacts
Lars Mattsson
Interim EVP Brand & Communication
Phone: +46 10 335 0043
Caroline Örmgård
Head of Public & Media Relations
Phone: +46 10 335 0041
Contact us online
Click below to fill in the appropriate form. We will be in touch shortly.
Are you looking for
Image Gallery
Diverse picture format made available for press article purpose
About us
All you need to know about Getinge a one glance
Urgent Medical Device Correction
Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)
Don't miss anything
Click on the icons and follow us!